Studies reporting on efficacy and safety of NSAIDs after orthopedic fracture in adult patients
Author (ID) | State or country | Year | Study design | Study size | Patient population (types of fractures and surgery) | NSAIDs used | Duration (time or doses) | Indication for NSAIDs | Outcomes measured |
Mehta23 | India | 1986 | Randomized control trial | 254 | Long bone fractures who underwent fixation | Dipyrone (500 mg) or ASA (500 mg) | One dose | Pain control | Pain |
Hunter22 | USA | 2020 | Retrospective cohort | 502 | Malleolar ankle fractures who underwent fixation | ASA (325 mg) | Daily for 6 to 8 weeks | DVT prophylaxis | Non-union |
Moed21 | USA | 1984 | Retrospective cohort | 35 | Acetabular fractures who underwent fixation | Indomethacin (25 mg) | TID for 6 weeks | Prevent HO | Non-union |
Jeffcoach19 | USA | 2014 | Retrospective cohort | 193 | Femur, tibia and/or humeral fractures | 8 different NSAIDs | IQR 1.0 to 8.5 doses | Pain control | Non-union |
Buchheit18 | USA | 2018 | Retrospective cohort | 309 330 | Bone fracture in year 2011 | Any NSAID, dose not reported | Acute (<30 days) Chronic (≥30 days) | Not reported | Non-union |
Adolphson17 | Sweden | 1993 | Randomized control trial | 33 | Colles’ fracture in postmenopausal women | Piroxicam (20 mg) | Daily for 8 weeks | Reduction in osteopenia | Pain |
Weisz16 | USA | 2021 | Randomized control trial | 99 | Fracture of ribs, face, extremities or pelvis | IV Ibuprofen (800 mg) | Eight doses over 2 days | Pain | Pain, OMEs |
Sagi15 | USA | 2014 | Randomized control trial | 98 | Acetabular fractures who underwent fixation | Indomethacin (75 mg) | Daily for 3 days, 1 week or 6 weeks | Prevent HO | Non-union |
McDonald14 | USA | 2019 | Randomized control trial | 128 | Ankle fractures who underwent operative treatment | Ketorolac 30 mg IV intra-op+20 tabs Ketorolac 10 mg | 7 days | Pain | Pain, OMEs, non-union |
Burd13 | USA | 2003 | Randomized control trial | 112 | Acetabular fractures who underwent fixation | Indomethacin (25 mg) | Three times a day for 6 weeks | Prevent HO | Non-union |
Zura12 | USA | 2016 | Retrospective cohort | 309 330 | Bone fracture in year 2011 | Any NSAID, dose not reported | Not reported | Not reported | Non-union |
Ortiz10 | Mexico | 2010 | Randomized control trial | 49 | Ankle fracture and pain >5/10 | Ketorolac (10 mg) Diclofenac (70 mg) Etoricoxib (60 mg) | Two doses | Pain | Pain |
Bayouth9 | USA | 2013 | Retrospective cohort (matched) | 42 | Rib fractures | IV Ibuprofen | 600 to 800 mg every 6 hours | Pain | Pain, OMEs |
Eftekharian8 | Iran | 2017 | Randomized clinical trial | 50 | Mandibular fracture | Ketorolac | Single postoperative dose | Pain | Pain |
Xu7 | USA | 2016 | Randomized clinical trial | 63 | Femoral or tibiofibular fractures | Ketorolac | In postoperative analgesia pump | Pain | Pain, OMEs |
Tucker6 | USA | 2020 | Retrospective cohort | 17 689 | Operatively treated long-bone fractures | NSAID No NSAID | Up to 90 days | Not reported | Non-union |
Aliuskevicius3 | Denmark | 2021 | Randomized control trial | 96 | Non-surgically treated Colles’ fractures | Ibuprofen | 3 days or 7 days | Pain control | Pain |
Haines5 | USA | 2020 | Retrospective cohort | 190 057 | ≥65 year old who underwent hip or femur fixation for fracture | Any NSAID | Not reported | Not reported | OMEs, acute kidney injury |
George4 | USA | 2020 | Retrospective cohort | 339 864 | Single long-bone fracture or commonly paired long-bone fractures | Any NSAID, dose not reported; COX-2 or non-selective | Not reported | Not reported | Non-union |
†Institution specific.
‡For both groups combined.
ASA, aspirin; DVT, deep vein thrombosis; HO, heterotopic ossification; NSAIDS, non-steroidal anti-inflammatory drugs; OME, oral morphine equivalents.